A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Codeine-N-oxide
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Dexverapamil.
Codeine-N-oxide
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Dexverapamil.
Codeine-N-oxide
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Dexverapamil.
Codeine-N-oxide
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Dexverapamil.
Codeine-N-oxide
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Dexverapamil.
Codeine-N-oxide
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Dexverapamil.
Codeine-N-oxide
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Dexverapamil.
Codeine-N-oxide
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Dexverapamil.
Codeine-N-oxide
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Dexverapamil.
Codeine-N-oxide
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Dexverapamil.
Codeine-N-oxide
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dexverapamil.
Codeine-N-oxide
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Dexverapamil.
Codeine-N-oxide
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Dexverapamil.
Codeine-N-oxide
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Dexverapamil.
Codeine-N-oxide
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Dexverapamil.
Codeine-N-oxide
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Dexverapamil.
Codeine-N-oxide
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Dexverapamil.
Codeine-N-oxide
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Dexverapamil.
Codeine-N-oxide
Macimorelin
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Macimorelin.
Codeine-N-oxide
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Deutetrabenazine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3